Cost of depression in Europe.

By P. Sobocki, B. Jönsson, J. Angst, C. Rehnberg. Journal of Mental Health Policy and Economics, 2006

605 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/11980931ab621890d23e8044747bded118394125

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Michael Maes
2. Raz Yirmyia
3. Jens Noraberg
4. M. Kubera
5. S. Brené
6. J. Hibbeln
7. Sigrid Breit
8. G. Perini

Citations in the corpus

• Prevalence and clinical course of depression: a review. (2011, background): “Direct healthcare costs amounted to 36% and indirect costs due to morbidity and mortality amounted to 64% (Sobocki et al., 2006).”
• Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018, background): “9% (US) (105), the cost of depression poses a significant economic burden to our society (106).”
• The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression (2009, background): “This makes depression a major concern to the personal and economic welfare (Sobocki et al. 2006).”